Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 92Observational 2

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Ototoxicity 1Hematologic Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Surveys and Questionnaires 39Blood Specimen Collection 23Specimen Handling 14Radiotherapy 12Surgical Procedures, Operative 10Magnetic Resonance Spectroscopy 10Interviews as Topic 10Observation 9Drug Therapy 9Data Collection 8Immunotherapy 7Watchful Waiting 5Tomography, X-Ray Computed 5Radiosurgery 5Nivolumab 5Mental Status and Dementia Tests 5Mastectomy, Segmental 5Immune Checkpoint Inhibitors 5Biopsy 5ribociclib 4palbociclib 4lorlatinib 4Therapeutics 4Positron Emission Tomography Computed Tomography 4Magnetic Resonance Imaging 4Ipilimumab 4High-Throughput Nucleotide Sequencing 4Hepatectomy 4Echocardiography 4Bevacizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Observational × Vincristine × Clear all
NCT05359237 2026-02-06

Vincristine Pharmacokinetics in Infants

Children's Oncology Group

Active not recruiting
83 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡